TransCode Therapeutics, Inc. Common Stock
€4.162
EUR
Last updated on --.
24h volume2.32M
24h highest6.1215 EUR
24h lowest3.1426 EUR
24h Price movement-8.61%
RNAZ recent prices
24 Hours
-8.61%-€0.39207
30 days
-38.55%-€2.611
60 days
-46.09%-€3.559
90 days
-49.69%-€4.111
Key data
Previous close4.5541 EUR
Market cap4.21M EUR
Volume2.32M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-39.6210 EUR
Net income (FY)-34.78M EUR
Revenue (FY)--
Last report dateMay 15, 2026
About TransCode Therapeutics, Inc. Common Stock
HeadquartersBOSTON
Employees (FY)12.00
Net income per employee (FY)-2.90M EUR
Listed onNasdaq
RNAZ conversion tables
 |  |
|---|---|
| 0.5 RNAZ | 2.081 EUR |
| 1 RNAZ | 4.162 EUR |
| 5 RNAZ | 20.81 EUR |
| 10 RNAZ | 41.62 EUR |
| |
|---|---|
| 0.5 EUR | 0.12013 RNAZ |
| 1 EUR | 0.24027 RNAZ |
| 5 EUR | 1.201 RNAZ |
| 10 EUR | 2.402 RNAZ |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
RNAZ is trading at €4.162, -8.61% over the last 24 hours. Track live moves on the price chart at the top of this page.
The RNAZ stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. RNAZ is currently trading at €4.162, -8.61% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on RNAZ price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. RNAZ's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from RNAZ; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against RNAZ's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
TransCode Therapeutics, Inc. Common Stock's market cap is currently 4.21M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.32M
24h highest6.1215 EUR
24h lowest3.1426 EUR
24h Price movement-8.61%
Start trade with RNAZ Perpetual
Sign up to trade